ADAR1 Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,143
| Closed | -$292K | – | 271 |
|
|
2025
Q3 | $292K | Sell |
6,143
-27,000
| -81% | -$1.31M | 0.03% | 163 |
|
|
2025
Q2 | $1.77M | Sell |
33,143
-38,000
| -53% | -$1.73M | 0.29% | 59 |
|
|
2025
Q1 | $2.88M | Buy |
71,143
+55,836
| +365% | +$2.37M | 0.55% | 49 |
|
|
2024
Q4 | $426K | Sell |
15,307
-7,700
| -33% | -$233K | 0.09% | 118 |
|
|
2024
Q3 | $660K | Sell |
23,007
-2,500
| -10% | -$65.2K | 0.11% | 100 |
|
|
2024
Q2 | $598K | Buy |
25,507
+23,700
| +1,312% | +$507K | 0.12% | 90 |
|
|
2024
Q1 | $45.6K | Sell |
1,807
-14,193
| -89% | -$341K | 0.01% | 185 |
|
|
2023
Q4 | $374K | Buy |
+16,000
| New | +$316K | 0.17% | 66 |
|
